SIGN UP
LOG IN
UPDATE 1-Adidas surges as strong momentum helps Q1 beat, triggers outlook hike
Adidas shares hit highest level in over two years after better-than-expected quarterly results. German sportswear giant raised 2024 guidance on stronger momentum. Growth driven by strong demand momentum in retro styles and performance categories. Adidas has been undergoing a turnaround after suspending sales of Yeezy sneaker line.
Reuters · 2d ago
UPDATE 2-Adidas shares surpass two-year high as 'terrace' sneaker trend boosts brand heat
Adidas shares surpass two-year high as 'terrace' sneaker trend boosts brand heat. Shares up over 8% on Q1 beat, hiked outlook on strong demand in retro styles. Growth driven by strong demand momentum in "terrace" retro styles, analysts say. German sportswear giant reported quarterly results above expectations and hiked 2024 guidance. Analysts see guidance as conservative.
Reuters · 2d ago
UPDATE 2-Insurer Bowhead Specialty's profit more than doubled in 2023, IPO filing shows
Insurer Bowhead Specialty's profit more than doubled in 2023, IPO filing shows. U.S. Initial public offering market expected to recover in 2024, after two-year dry spell. Insurance underwriting company's net premiums written up 36.5% to $334.7 million. The company will list on the New York Stock Exchange.
Reuters · 6d ago
BUZZ-Stifel raises PT for U.S. rails on long-term growth prospects
Stifel raises PT for U.S. Rails on long-term growth prospects. Brokerage rates CSX at "buy", UNP and NSC at "hold" Low gas prices have caused a sharp decline in coal demand/carloads - Stifel.
Reuters · 04/12 11:48
BUZZ-Nurix Therapeutics drops after upsized $175 mln stock offering
Nurix Therapeutics Inc's shares down 5.3% at $16.30 premarket after upsized $175 mln stock offering. Biopharma firm Nurix announced 11.7 mln shares to be sold at $15 each. Nurix shares closed up 27% last week.
Reuters · 04/12 11:36
STIFEL FINANCIAL CORP <SF.N>: CITIGROUP RAISES TARGET PRICE TO $80 FROM $74
Reuters · 04/11 10:50
U.S. RESEARCH ROUNDUP-Airbnb, Albemarle, Biogen
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Airbnb, Albemarle and Biogen among those with revised targets. AIG, Aflac and Allstate among companies with new targets for the day. Analysts cut target prices on some of the companies.
Reuters · 04/11 07:32
STIFEL FINANCIAL CORP <SF.N>: UBS RAISES TARGET PRICE TO $84 FROM $78
Reuters · 04/05 14:04
Webull offers STIFEL FINANCIAL stock information, including NYSE: SF-PRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SF-PRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading SF-PRA stock methods without spending real money on the virtual paper trading platform.